A post-reaction regimen for CRC patients manifesting hypersensitivity to oxaliplatin : an effective alternative not to rule out an important option of treatmentC. Nisi, Antonio Frassoldati, A. Moretti et al.|Annals of Oncology|2015Cited by 1
Estrogen receptor mutation: a new strategy to overcome endocrine resistanceAndrea Moretti, Antonio Frassoldati, Luca Martella et al.|Annals of Oncology|2017Cited by 1